Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

127.04

+6.32 (5.24%)

as of Jul 24, 2026, 8:00:00 pm Market Open.

221 watching

Investor Insights

Jul 24, 2026, 12:00 am

This summary was created by AI, based on 36 opinions in the last 12 months.

Thomson Reuters Corp (TRI) has been experiencing significant scrutiny in the market due to concerns about the impact of artificial intelligence (AI) on its core businesses, particularly in the legal and accounting sectors. While many analysts acknowledge the company's strong financial fundamentals, including consistent topline growth and a robust balance sheet, fears surrounding AI's potential to disrupt their proprietary data remain prevalent. Opinions are divided; some believe TRI's unique data offerings will enable it to withstand AI-related challenges, while others express skepticism about the stock's future trajectory, given its previous high valuation and current trading multiples. Overall, the market sentiment towards TRI is cautious, indicating potential for both recovery and continued volatility in the stock's price as it navigates these AI-driven uncertainties.

Consensus

Cautious

Valuation

Fair Value

Similar

RELX, REL

HOLD

Have had to be extraordinarilly patient with the stock. Was a high multiple stock. Still likes its growth strategy, supplying data base management. May take some time.

WEAK BUY

Has always been valued at a fairly high multiple. Because of this, hasn't seen too much of a total return expectation from the company. At this level, it would be a reasonable trade, but does get expensive fairly quickly because of its valuation point and the slower growth rate.

HOLD

A company that seems to be doing most of the right things, but hasn't seen the stock move at all and creating the earnings growth. Haven't given up on it yet.

DON'T BUY

A solid company, but the problem is, it doesn't generate enough free cash flow to sustain this price. Their valuation is in the $25/30 range. Margins are stretched because pricing power is not there.

PAST TOP PICK

(A Top Pick Aug 9/04. Down 2.5%.) Still likes. An enquiry in one of their divisions by Spitzer knocked the stock back Until that is resolved, the stock will be in a holding pattern.

SELL

Dead money. Has beeen going through a transition over a number of years.

TOP PICK

Has lagged. They beat expectations and raised their guidance again last quarter. Should do it again.

BUY

Growing and doing well in their core markets. Has been overvalued, but is now at the point where it can grow at the level that its cash flows are growing. Expects a 10/12% growth.

DON'T BUY

Have some great assets. Lots of cash. To make accretive acquisitions they have to pay significant $'s.

BUY

As time goes on, expects to see them expand into more and more scientific and engineering endeavours. Good long term hold.

PAST TOP PICK

(A Top Pick Aug 9/04. Down 4%.) Disappointed with the stock performance. Would still buy at this price. Made a big turn around in the last 2 quarterly earnings.

BUY

Starting to deliver on the earnings growth. Earnings should be up about 17% this year and 18% next year.

DON'T BUY

A big disappointment in Canadian blue chip stocks. Can't seem to increase their earnings enough to justify the multiple. Gave up on it 2 years ago.

DON'T BUY

Marvelous world-class company with great products. May tend to overpay for their assets at the expense of near-term earnings.

TOP PICK

very well run premium company. Good free cash will come out with very limited downside.

Showing 526 to 540 of 715 entries

Most Recent Experts

Andrew Pink

LDIC

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)